Ulcerative colitis
Conditions
Interventions
AI Group:Artificial intelligence-assisted diagnosis
Physician Group:Physician's diagnosis
Sponsors
Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients were diagnosed with UC according to the consensus opinion on the diagnosis and treatment of IBD in Beijing in 2018 in China. 2. Patients were 18-75 years old (inclusive), including male and female. 3. Patients underwent histopathological examination after biopsy. 4. Patients understood the nature, significance, possible benefits, possible inconveniences and potential risks of the trial in detail before the trial, understood the research procedures and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. During the follow-up process, diagnosis were changed and were not UC, or patients had serious comorbidities (such as malignant tumors, severe heart, brain, kidney, and liver diseases). 2. Patients had colonic stenosis, or had undergone colorectal surgery, and could not complete the entire colorectal examination and biopsy. 3. Patients could not undergo biopsy. 4. Patients had abnormal coagulation function, which were judged to be clinically significant by the investigators. 5. Patients were pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Histologic remission rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Endoscopic remission rate;Incidence of adverse events and serious adverse events;Clinical remission rate; | — |
Countries
China
Contacts
Public ContactChen Liping
Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Outcome results
None listed